Intractable Self-harm-What Support is Effective?
Svårbehandlat självskadebeteende-Vilka Insatser är Effektiva?
1 other identifier
observational
30
1 country
1
Brief Summary
The aim of this project is to evaluate a novel treatment program for individuals with intractable and lethal self-harm. The main questions are: 1: Is there, in individuals with intractable self-harm, a relevant improvement in daily functioning and is this improvement related to the provided interventions? The secondary research questions are: 2\. Is there, in individuals with intractable self-harm, a relevant improvement in frequency and severity of self-harm? 3\. Is there, in individuals with intractable self-harm, a relevant improvement in voluntary hospital admissions? 4\. Is there, in individuals with intractable self-harm, a relevant improvement in compulsary hospital admissions? 5\. Is there, in individuals with intractable self-harm, a relevant improvement in the use of medication pro re nata? 6\. Is there, in individuals with intractable self-harm, a relevant improvement in cost-effectiveness related to the provided interventions?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2023
CompletedFirst Submitted
Initial submission to the registry
October 19, 2023
CompletedFirst Posted
Study publicly available on registry
October 25, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
April 29, 2026
April 1, 2026
3.3 years
October 19, 2023
April 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The World Health Organization Disability Assessment Schedule II (WHODAS 2.0)
Level of daily functioning and disability in the domains of cognition, mobility, self-care, getting along with other people and life activities.
Monthly from baseline to endpointat 24 months and at follow-up at 36 months.
Secondary Outcomes (3)
Five Self-harm behaviour groupings measure (5S-HM)
Weekly from baseline to endpointat 24 months and at follow-up at 36 months.
The 5-level EQ-5D
Monthly from baseline to endpointat 24 months and at follow-up at 36 months.
Cost effectiveness
Monthly from baseline to endpointat 24 months and at follow-up at 36 months.
Study Arms (1)
Study group
Individuals with current severe, imminent and lethal self-harm with a history of at least two interventions without sufficient reduction of self-harm or suffering.
Interventions
Extensive assessments. Consultation and training for existing treatment providers and caregivers. Network-meetings for providers and caregivers.
Eligibility Criteria
A group of individuals with severe self-harm, commonly with comorbid psychiatric diagnoses and cognitive challanges.
You may qualify if:
- Having tried or made serious attempt to try at least two different interventions with evidence to reduce self-harm, without sufficient reduction in suffering or self-harm
You may not qualify if:
- Need for translation services to complete measures or interviews
- Not able to complete measures or interviews
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Highly Specialized Unit for Self-Harm Behaviours, Skåne
Lund, Skåne County, 22185, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 19, 2023
First Posted
October 25, 2023
Study Start
September 1, 2023
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
April 29, 2026
Record last verified: 2026-04